Sungho Bea, PharmD, PhD

Postdoctoral fellow
Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, United States

Sungho Bea, PharmD, PhD, is a pharmacoepidemiologist trained at the School of Pharmacy, Sungkyunkwan University, South Korea. He earned his PharmD from Yeungnam University. His research interests encompass pharmacoepidemiology, with specific focuses on the comparative effectiveness and safety of drugs for metabolic diseases, drug-drug interactions, and bridging the gap between randomized controlled trials (RCT) and real-world evidence (RWE).

Disclosure information not submitted.

Presentation(s):

• Glucagon-Like Peptide 1 Receptor Agonists and Risk of Thyroid Cancer: An International Multisite Cohort Study in Canada, Denmark, Norway, Sweden, South Korea and Taiwan

  Tuesday, August 27, 2024
  8:15 AM – 8:30 AM CEST

• Dementia Associated With Sodium-Glucose Cotransporter-2 Inhibitors Versus Glucagon-Like Peptide-1 Receptor Agonists: A Population-Based Cohort Study

  Tuesday, August 27, 2024
  1:30 PM – 1:45 PM CEST

• Risk of Hepatic Events Associated with Use of SGLT-2 Inhibitors Versus GLP-1RA, and Thiazolidinedione Among Patients with Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes

  Wednesday, August 28, 2024
  2:15 PM – 2:30 PM CEST